Stock listing
NASDAQ:MGRX Mangoceuticals, Inc. Stock
Home listing (NASDAQ) of Mangoceuticals, Inc.
Follow Mangoceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MGRX
$0.233 USD -0.021 (-8.2%)
Close on Oct 30, 2026
- Day range
- $0.229 – $0.260 USDOct 30, 2026
- Volume
- 521,676 sharesOct 30, 2026
- Market cap
- $5.19M USDAt the close on Oct 30, 2026 · price × 22.22M shares outstanding
- 52-week range
- $0.162 – $2.410 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $6.34M USDMedian day 577,500 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MGRX · Home | $0.233 USD | -0.021 (-8.2%) | 521,676 | $0.257 | $0.260 | $0.229 | $0.254 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:MGRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.233 | -0.021 | -8.2% | $0.257 | $0.260 | $0.229 | 521,676 | |
| $0.254 | -0.004 | -1.5% | $0.269 | $0.270 | $0.243 | 233,512 | |
| $0.258 | +0.010 | +4.1% | $0.251 | $0.265 | $0.248 | 380,753 | |
| $0.248 | +0.004 | +1.6% | $0.250 | $0.260 | $0.218 | 130,240 | |
| $0.244 | +0.012 | +5.3% | $0.226 | $0.254 | $0.222 | 317,296 | |
| $0.232 | -0.012 | -4.9% | $0.249 | $0.258 | $0.231 | 290,700 | |
| $0.244 | -0.051 | -17.3% | $0.296 | $0.305 | $0.236 | 926,700 | |
| $0.295 | -0.005 | -1.7% | $0.291 | $0.305 | $0.291 | 76,000 | |
| $0.300 | +0.020 | +7.1% | $0.290 | $0.305 | $0.280 | 176,800 | |
| $0.280 | -0.010 | -3.4% | $0.290 | $0.309 | $0.280 | 752,700 | |
| $0.290 | -0.031 | -9.7% | $0.336 | $0.345 | $0.285 | 262,700 | |
| $0.321 | -0.007 | -2.1% | $0.340 | $0.362 | $0.320 | 663,700 | |
| $0.328 | -0.044 | -11.8% | $0.375 | $0.380 | $0.307 | 676,300 | |
| $0.372 | -0.011 | -2.9% | $0.380 | $0.394 | $0.370 | 299,200 | |
| $0.383 | -0.039 | -9.2% | $0.420 | $0.420 | $0.381 | 449,300 | |
| $0.422 | -0.010 | -2.3% | $0.435 | $0.440 | $0.410 | 431,700 | |
| $0.432 | -0.012 | -2.7% | $0.435 | $0.460 | $0.423 | 583,800 | |
| $0.444 | -0.006 | -1.3% | $0.433 | $0.478 | $0.430 | 646,100 | |
| $0.450 | +0.032 | +7.7% | $0.423 | $0.456 | $0.411 | 831,700 | |
| $0.418 | -0.019 | -4.3% | $0.427 | $0.438 | $0.409 | 576,700 | |
| $0.437 | -0.044 | -9.1% | $0.426 | $0.444 | $0.426 | 876,200 | |
| $0.481 | +0.053 | +12.4% | $0.430 | $0.520 | $0.425 | 2,132,400 | |
| $0.428 | -0.017 | -3.8% | $0.431 | $0.445 | $0.428 | 204,300 | |
| $0.445 | +0.060 | +15.6% | $0.386 | $0.459 | $0.380 | 1,139,000 | |
| $0.385 | -0.081 | -17.4% | $0.450 | $0.457 | $0.370 | 1,001,800 | |
| $0.466 | +0.002 | +0.4% | $0.452 | $0.479 | $0.452 | 83,200 | |
| $0.464 | +0.015 | +3.3% | $0.439 | $0.480 | $0.435 | 557,600 | |
| $0.449 | +0.018 | +4.2% | $0.425 | $0.460 | $0.413 | 407,700 | |
| $0.431 | -0.020 | -4.4% | $0.450 | $0.457 | $0.410 | 472,700 | |
| $0.451 | -0.025 | -5.3% | $0.465 | $0.480 | $0.444 | 435,600 | |
| $0.476 | +0.031 | +7.0% | $0.450 | $0.480 | $0.395 | 1,590,200 | |
| $0.445 | -0.007 | -1.5% | $0.445 | $0.460 | $0.437 | 304,300 | |
| $0.452 | +0.032 | +7.6% | $0.430 | $0.472 | $0.430 | 1,079,400 | |
| $0.420 | +0.010 | +2.4% | $0.410 | $0.440 | $0.405 | 406,900 | |
| $0.410 | +0.007 | +1.7% | $0.392 | $0.420 | $0.385 | 578,300 | |
| $0.403 | +0.018 | +4.7% | $0.380 | $0.408 | $0.376 | 287,800 | |
| $0.385 | -0.031 | -7.5% | $0.404 | $0.414 | $0.380 | 150,000 | |
| $0.416 | +0.005 | +1.2% | $0.420 | $0.420 | $0.404 | 192,800 | |
| $0.411 | 0.000 | 0.0% | $0.403 | $0.420 | $0.392 | 278,600 | |
| $0.411 | +0.021 | +5.4% | $0.386 | $0.422 | $0.375 | 519,700 | |
| $0.390 | +0.006 | +1.6% | $0.377 | $0.399 | $0.376 | 200,800 | |
| $0.384 | -0.007 | -1.8% | $0.378 | $0.398 | $0.373 | 188,100 | |
| $0.391 | +0.001 | +0.3% | $0.390 | $0.395 | $0.373 | 212,900 | |
| $0.390 | -0.012 | -3.0% | $0.402 | $0.402 | $0.380 | 252,300 | |
| $0.402 | +0.002 | +0.5% | $0.391 | $0.424 | $0.390 | 430,400 | |
| $0.400 | +0.027 | +7.2% | $0.369 | $0.426 | $0.369 | 758,000 | |
| $0.373 | -0.015 | -3.8% | $0.388 | $0.388 | $0.363 | 275,600 | |
| $0.388 | +0.005 | +1.2% | $0.360 | $0.409 | $0.360 | 559,427 | |
| $0.383 | -0.039 | -9.2% | $0.369 | $0.385 | $0.360 | 955,686 | |
| $0.422 | +0.036 | +9.3% | $0.380 | $0.430 | $0.365 | 1,145,800 | |
| $0.386 | -0.032 | -7.7% | $0.406 | $0.408 | $0.383 | 1,030,300 | |
| $0.418 | -0.052 | -11.1% | $0.449 | $0.468 | $0.417 | 1,041,400 | |
| $0.470 | -0.059 | -11.2% | $0.507 | $0.512 | $0.462 | 1,250,900 | |
| $0.529 | -0.005 | -0.9% | $0.490 | $0.549 | $0.490 | 1,905,100 | |
| $0.534 | +0.001 | +0.2% | $0.584 | $0.598 | $0.472 | 21,113,200 | |
| $0.533 | 0.000 | 0.0% | $0.520 | $0.590 | $0.520 | 27,618,300 | |
| $0.533 | -0.013 | -2.4% | $0.519 | $0.553 | $0.488 | 967,200 | |
| $0.546 | -0.049 | -8.2% | $0.566 | $0.602 | $0.535 | 1,370,800 | |
| $0.595 | +0.103 | +20.9% | $0.465 | $0.610 | $0.456 | 4,987,200 | |
| $0.492 | -0.035 | -6.6% | $0.480 | $0.494 | $0.450 | 4,270,700 | |
| $0.527 | +0.101 | +23.7% | $0.592 | $0.630 | $0.487 | 52,479,900 | |
| $0.426 | -0.032 | -7.0% | $0.414 | $0.468 | $0.400 | 62,970,800 | |
| $0.458 | -0.078 | -14.6% | $0.470 | $0.510 | $0.422 | 3,589,200 | |
| $0.536 | -0.021 | -3.8% | $0.432 | $0.555 | $0.416 | 15,123,800 | |
| $0.557 | +0.263 | +89.5% | $0.641 | $1.250 | $0.517 | 512,124,600 | |
| $0.294 | -0.259 | -46.8% | $0.420 | $0.420 | $0.261 | 80,544,800 |
- Ticker
- NASDAQ:MGRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 9, 2026
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Latest news
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Oct 9, 2026
Closed $0.383 (-9.2%) on Oct 12, 2026
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche
Oct 1, 2026
Closed $0.481 (+12.4%) on Oct 1, 2026
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
Aug 13, 2026
Closed $0.534 (+0.2%) on Aug 14, 2026
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
Aug 5, 2026
Closed $0.527 (+23.7%) on Aug 6, 2026
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
Aug 4, 2026
Closed $0.426 (-7.0%) on Aug 5, 2026
Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
Jul 30, 2026
Closed $0.294 (-46.8%) on Jul 30, 2026
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
Mar 17, 2026
Closed $0.40 (-1.0%) on Mar 17, 2026
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
Mar 6, 2026
Closed $0.373 (+0.3%) on Mar 6, 2026
Financings
Registered direct offering of units of one share of common stock and one warrant
Oct 9, 2026
Closed: US$500,000 raised · US$0.75 a unit · one warrant
Use of proceeds: Additional working capital
Strategic investment of membership interests in MangoRx IP Holdings, LLC
Oct 1, 2026
Tranche closed: US$1.75M raised
Use of proceeds: To advance commercialization of the antiviral intellectual property portfolio held by MangoRx IP
Mangoceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 15 in the last 12 months · 94 in all · newest Oct 9, 2026 · oldest 2023
Where Mangoceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MGRX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MGRX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Mangoceuticals, Inc.